Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19dabeee1773c9cb4b5443971e1b14fe |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 |
filingDate |
2007-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2013-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0b5e3a0b4d94e50de63da25846b9a6d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e049a88f91b39a0f993a305b24a2628d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f59f1755bc704730848d87384e15ce23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffb9d2e1469673c15e903f8e4b2c80f4 |
publicationDate |
2013-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2036566-B1 |
titleOfInvention |
Use of 20(s)-protopanoxadiol in manufacture of antidepressants |
abstract |
The invention covers the usage of 20(S)-protopanaxadiol in the formulation of medicaments for treating depressive affective disorders. The pharmacological test results indicated that the compound could significantly elevate the level of NE, 5-HT and HAV in the brains of model rats and obviously improve 5-HTP-induced tremor and LD-induced behavior, and inhibit the reuptake of 5-HT and NA. |
priorityDate |
2006-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |